MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
0.7710
-0.0290
-3.63%
After Hours: 0.7710 0 0.00% 16:04 03/13 EDT
OPEN
0.7900
PREV CLOSE
0.8000
HIGH
0.7999
LOW
0.7624
VOLUME
18.19K
TURNOVER
--
52 WEEK HIGH
7.98
52 WEEK LOW
0.7321
MARKET CAP
2.25M
P/E (TTM)
-0.1888
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 6d ago
InMed outlines 2026 development plans for lead programs
TipRanks · 6d ago
InMed Pharmaceuticals provides development outlook for 2026
TipRanks · 6d ago
InMed targets 2027 Phase 1 trial start for INM-901 and plans FDA pre-IND meeting in Q3 2026
Reuters · 6d ago
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
Newsfile · 6d ago
Weekly Report: what happened at INM last week (0302-0306)?
Weekly Report · 6d ago
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
TipRanks · 03/06 22:21
InMed winds down BayMedica commercial operations to focus on drug development pipeline
Reuters · 03/06 22:06
More
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.